Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2025-12-26 @ 3:58 AM
Study NCT ID:
NCT05177718
Status:
TERMINATED
Last Update Posted:
2024-04-18
First Post:
2021-12-13
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Natalizumab and Chronic Inflammation
Sponsor:
Vanderbilt University Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-16
Start Date Type:
ACTUAL
Primary Completion Date:
2023-04-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-04-05
Completion Date Type:
ACTUAL
First Submit Date:
2021-12-13
First Submit QC Date:
None
Study First Post Date:
2022-01-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-03-11
Results First Submit QC Date:
None
Results First Post Date:
2024-04-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-17
Last Update Post Date:
2024-04-18
Last Update Post Date Type:
ACTUAL